Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals Inc appears in FDA public data with 3 recalls, 0 510(k) clearances, 23 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0767-2026, Class II) was initiated on July 28, 2026.
Summary
- Total Recalls
- 3
- 510(k) Clearances
- 0
- Inspections
- 23
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0767-2026 | Class II | Libtayo (cemiplimab-rwlc) Injection, 350 mg/7 mL (50 mg/mL), For Intravenous Infusion After Dilution | July 28, 2026 |
| D-0531-2024 | Class II | EYLEA, (aflibercept) Injection, For Intravitreal injection, 2 mg (0.05mL of a 40mg/mL solution), Sin | May 15, 2024 |
| D-0479-2024 | Class II | EYLEA, (aflibercept) Injection, 2 mg (0.05mL of a 40mg/mL solution), Single-dose Pre-filled Syringe, | April 23, 2024 |